Kevin Robb is an Operating Executive at Seven Hills Capital, where he focuses on executing investment strategies and value creation for new portfolio companies. With over seven years of healthcare services experience, his expertise spans M&A, due diligence, integration, and managed care functions for middle-market companies. In his current role, Kevin is leading efforts related to making new platform investments, specifically in the Infusion Services space.

Prior to joining Seven Hills, Kevin was the Vice President of Business Development for PhyNet Dermatology, managing national acquisition efforts for the 100+ clinic, 300+ provider MSO. He started his career as a CPA with Capital One and has been healthcare focused ever since joining the Healthcare Transaction Advisory Team within Berkeley Research Group.

Kevin is originally from Winchester, VA and holds a BBA and MS in accountancy from James Madison University. Outside of Seven Hills, Kevin enjoys chasing around his two young boys, reading, playing golf, and seeing live music.